BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 27, 2004
View Archived Issues
Northfield To Support PolyHeme Pivotal Trial With $15M Financing
Blood substitute developer Northfield Laboratories Inc. topped off the tank with $15 million in financing to fund a pivotal trial of its lead product, PolyHeme. (BioWorld Today)
Read More
Cypress Licenses Collegium's Patent Portfolio For Milnacipran
Read More
No Cure In Sight, No Cause In View, Gastroenterologists Soldier On To Try Assuagement Of Crohn's Illness
Read More
CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More